Table 2 Summary of the main characteristics of TFEB translocation renal cell carcinoma and TFEB amplification renal cell carcinoma
Cases | Age (Mean, year) | Sex (Male: female) | Size (Mean, cm) |  ≥ pT3 | Metastasis (follow-up) | Papillary | Tubulopapillary | Pseudopapillary | Morphologic features | Necrosis | Calcification | Pigment | TFEB | IHC(Positivity) | HMB45 | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eosinophilic | Clear Cell | cathepsin k | Melan-A | ||||||||||||||||
TFEB- | |||||||||||||||||||
 Amplified Tumors TFEB | 50 | 63.46 | 3:2 | 8.73 | 30/50 | 15/20 | 14/45 | 18/45 | 6/45 | 27/45 | 20/45 | 7/45 | / | / | 5/7 | 16/27 | 28/36 | 6/30 | |
 Translocated Tumors | 40 | 45.6 | 2:3 | 7.09 | 8/24 | 1/8 | 5/25 | 4/25 | 3/25 | 7/25 | 16/25 | 3/25 | 3/25 | 3/25 | 12/12 | 36/36 | 34/35 | 21/30 | |
p | 0.000 | / | 0.088 | 0.047 | 0.004 | 0.406 | 0.059 | 1.000 | 0.013 | 0.140 | 1.000 | / | / | 0.123 | 0.000 | 0.028 | 0.000 | ||